Palmar Hyperhidrosis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, Analysis of Clinical Trials, Therapies, MOA, ROA, and Developments | Dryox Health, Journey Medical Corp, Atacama Therapeutics, GlaxoSmithKline, Botanix Pharmaceuticals

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Palmar Hyperhidrosis pipeline constitutes 3+ key companies continuously working towards developing 3+ Palmar Hyperhidrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Palmar Hyperhidrosis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Palmar Hyperhidrosis Market.

The Palmar Hyperhidrosis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Palmar Hyperhidrosis Pipeline Report: https://www.delveinsight.com/sample-request/palmar-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Palmar Hyperhidrosis treatment therapies with a considerable amount of success over the years.
• Palmar Hyperhidrosis companies working in the treatment market are Dryox Health, Journey Medical Corp, Atacama Therapeutics, GlaxoSmithKline, Botanix Pharmaceuticals, Atacama Therapeutics, and others, are developing therapies for the Palmar Hyperhidrosis treatment
• Emerging Palmar Hyperhidrosis therapies in the different phases of clinical trials are- TTB gel, Glycopyrronium, Dexmecamylamine HCl, Umeclidinium, BBI-4000, AT-5214, and others are expected to have a significant impact on the Palmar Hyperhidrosis market in the coming years.
• In June 2024, Botanix Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for Sofdra (sofpironium) gel, 12.45%, to treat excessive underarm sweating (primary axillary hyperhidrosis).
• In March 2024, Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company focused on innovative treatments for brain health disorders, announced that the FDA has granted Breakthrough Therapy Designation to its MM120 (lysergide d-tartrate) program for treating generalized anxiety disorder (GAD). Additionally, the company reported that its Phase 2b study of MM120 in GAD achieved its key secondary endpoint, with 12-week topline data showing clinically and statistically significant durability of efficacy through Week 12.

Palmar Hyperhidrosis Overview
Palmar Hyperhidrosis is a medical condition characterized by excessive sweating of the palms, beyond what is necessary to regulate body temperature. This condition is often localized and can occur without physical exertion or heat. It can interfere with daily activities, causing discomfort and social anxiety. Palmar hyperhidrosis may be primary (idiopathic), with no underlying medical cause, or secondary, resulting from other conditions like hormonal imbalances or neurological disorders. Treatment options include topical antiperspirants, oral medications, Botox injections, and in severe cases, surgery such as sympathectomy.


Get a Free Sample PDF Report to know more about Palmar Hyperhidrosis Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/palmar-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Palmar Hyperhidrosis Drugs Under Different Phases of Clinical Development Include:
• TTB gel: Dryox Health
• Glycopyrronium: Journey Medical Corp
• Dexmecamylamine HCl: Atacama Therapeutics
• Umeclidinium: GlaxoSmithKline
• BBI-4000: Botanix Pharmaceuticals
• AT-5214: Atacama Therapeutics

Palmar Hyperhidrosis Route of Administration
Palmar Hyperhidrosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Palmar Hyperhidrosis Molecule Type
Palmar Hyperhidrosis Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Palmar Hyperhidrosis Pipeline Therapeutics Assessment
• Palmar Hyperhidrosis Assessment by Product Type
• Palmar Hyperhidrosis By Stage and Product Type
• Palmar Hyperhidrosis Assessment by Route of Administration
• Palmar Hyperhidrosis By Stage and Route of Administration
• Palmar Hyperhidrosis Assessment by Molecule Type
• Palmar Hyperhidrosis by Stage and Molecule Type

DelveInsight's Palmar Hyperhidrosis Report covers around 3+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Palmar Hyperhidrosis product details are provided in the report. Download the Palmar Hyperhidrosis pipeline report to learn more about the emerging Palmar Hyperhidrosis therapies at:
https://www.delveinsight.com/sample-request/palmar-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Palmar Hyperhidrosis Therapeutics Market include:
Key companies developing therapies for Palmar Hyperhidrosis are - Atacama Therapeutics, GlaxoSmithKline, Brickell Biotech, Inc., Candesant Biomedical, Dermira, Inc., and others

Palmar Hyperhidrosis Pipeline Analysis:
The Palmar Hyperhidrosis pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Palmar Hyperhidrosis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Palmar Hyperhidrosis Treatment.
• Palmar Hyperhidrosis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Palmar Hyperhidrosis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Palmar Hyperhidrosis market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Palmar Hyperhidrosis drugs and therapies-
https://www.delveinsight.com/sample-request/palmar-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Palmar Hyperhidrosis Pipeline Market Drivers
• Increasing Awareness and Diagnosis, Advancements in Treatment Options, High Unmet Medical Need, Rising Prevalence of Hyperhidrosis, Supportive Regulatory Environment, Expansion of Specialty Clinics, Technological Advancements, are some of the important factors that are fueling the Palmar Hyperhidrosis Market.

Palmar Hyperhidrosis Pipeline Market Barriers
• However, High Cost of Treatment, Side Effects and Risks, Lack of Awareness in Emerging Markets, Market Fragmentation, Stigma and Social Barriers, Regulatory Challenges, Limited Long-term Data, and other factors are creating obstacles in the Palmar Hyperhidrosis Market growth.

Scope of Palmar Hyperhidrosis Pipeline Drug Insight
• Coverage: Global
• Key Palmar Hyperhidrosis Companies: Dryox Health, Journey Medical Corp, Atacama Therapeutics, GlaxoSmithKline, Botanix Pharmaceuticals, Atacama Therapeutics, and others
• Key Palmar Hyperhidrosis Therapies: TTB gel, Glycopyrronium, Dexmecamylamine HCl, Umeclidinium, BBI-4000, AT-5214, and others
• Palmar Hyperhidrosis Therapeutic Assessment: Palmar Hyperhidrosis current marketed and Palmar Hyperhidrosis emerging therapies
• Palmar Hyperhidrosis Market Dynamics: Palmar Hyperhidrosis market drivers and Palmar Hyperhidrosis market barriers

Request for Sample PDF Report for Palmar Hyperhidrosis Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/palmar-hyperhidrosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Palmar Hyperhidrosis Report Introduction
2. Palmar Hyperhidrosis Executive Summary
3. Palmar Hyperhidrosis Overview
4. Palmar Hyperhidrosis- Analytical Perspective In-depth Commercial Assessment
5. Palmar Hyperhidrosis Pipeline Therapeutics
6. Palmar Hyperhidrosis Late Stage Products (Phase II/III)
7. Palmar Hyperhidrosis Mid Stage Products (Phase II)
8. Palmar Hyperhidrosis Early Stage Products (Phase I)
9. Palmar Hyperhidrosis Preclinical Stage Products
10. Palmar Hyperhidrosis Therapeutics Assessment
11. Palmar Hyperhidrosis Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Palmar Hyperhidrosis Key Companies
14. Palmar Hyperhidrosis Key Products
15. Palmar Hyperhidrosis Unmet Needs
16 . Palmar Hyperhidrosis Market Drivers and Barriers
17. Palmar Hyperhidrosis Future Perspectives and Conclusion
18. Palmar Hyperhidrosis Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Palmar Hyperhidrosis Market https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Palmar Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Palmar Hyperhidrosis Epidemiology https://www.delveinsight.com/report-store/palmar-hyperhidrosis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Palmar Hyperhidrosis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
• Interspinous Spacers Market: https://www.delveinsight.com/report-store/interspinous-spacers-market
• Dengue Fever Market: https://www.delveinsight.com/report-store/dengue-fever-market
• Chronic Hemodialysis Market: https://www.delveinsight.com/report-store/chronic-hemodialysis-market
• Brucellosis Market: https://www.delveinsight.com/report-store/brucellosis-market
• Childhood Atropine For Myopia Progression Market: https://www.delveinsight.com/sample-request/childhood-atropine-for-myopia-progression-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Cardiac Rhythm Management Devices Market: https://www.delveinsight.com/report-store/cardiac-rhythm-management-devices-market
• Tumor Ablation Market: https://www.delveinsight.com/report-store/tumor-ablation-market
• Fibromyalgia Market: https://www.delveinsight.com/report-store/fibromyalgia-market

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.